Levi Strauss & Co.: Barclays cuts target price to $26 from $27
LEVI•Barclays cut its target price for Levi Strauss & Co. to $26 from $27.
Related News
Lufax shareholders approve extension of Ping An Overseas convertible notes maturity
LU•
Acadia Pharmaceuticals: Leerink Partners cuts target price to $27 from $30
ACAD•
X4 Pharmaceuticals secures up to $150 million senior debt facility with K2 HealthVentures
XFOR•
Akamai to host investor call on third-quarter 2026 results
AKAM•
Tilray Brands Q1 revenue USD 257.147 million
TLRY•